Engagement in hepatitis C virus cascade of care and factors associated with testing among people who inject drugs in Iran.
Saved in:
| Title: | Engagement in hepatitis C virus cascade of care and factors associated with testing among people who inject drugs in Iran. |
|---|---|
| Authors: | Khezri M; Department of Epidemiology, School of Global Public Health, New York University, New York, NY, USA.; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran., Tavakoli F; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran., Mehmandoost S; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran., Sharafi H; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.; Research Centre, Centre Hospitalier de l'Université de Montréal (CRCHUM), Montreal, QC, Canada., Zamani O; World Health Organization Country Office, Tehran, Iran., Bazrafshani MS; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran., Nasiri N; Department of Epidemiology and Biostatistics, School of Public Health, Jiroft University of Medical Sciences, Jiroft, Iran., Mirzaei H; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran., Moameri H; Department of Epidemiology, School of Global Public Health, New York University, New York, NY, USA.; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran., Haghdoost AA; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran., McKnight C; Department of Epidemiology, School of Global Public Health, New York University, New York, NY, USA.; Center for Drug Use and HIV/HCV Research, New York, NY, USA., Des Jarlais D; Department of Epidemiology, School of Global Public Health, New York University, New York, NY, USA.; Center for Drug Use and HIV/HCV Research, New York, NY, USA., Karamouzian M; Centre on Drug Policy Evaluation, MAP Centre for Urban Health Solutions, St. Michael's Hospital, Toronto, ON, Canada.; Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada., Sharifi H; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran. hsharifi@kmu.ac.ir.; Institute for Global Health Sciences, University of California, San Francisco, San Francisco, CA, USA. hsharifi@kmu.ac.ir. |
| Source: | Harm reduction journal [Harm Reduct J] 2025 Apr 08; Vol. 22 (1), pp. 49. Date of Electronic Publication: 2025 Apr 08. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101153624 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-7517 (Electronic) Linking ISSN: 14777517 NLM ISO Abbreviation: Harm Reduct J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
